Antara Capital LP - INHIBIKASE THERAPEUTICS INC ownership

INHIBIKASE THERAPEUTICS INC's ticker is IKT and the CUSIP is 45719W106. A total of 25 filers reported holding INHIBIKASE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Antara Capital LP ownership history of INHIBIKASE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$299,000
-33.3%
403,000
+33.0%
0.01%
-7.1%
Q1 2022$448,000
+0.7%
303,0000.0%0.01%
-36.4%
Q4 2021$445,000
-22.7%
303,0000.0%0.02%
-50.0%
Q3 2021$576,000
-17.7%
303,000
+21.2%
0.04%
+15.8%
Q2 2021$700,000250,0000.04%
Other shareholders
INHIBIKASE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 937,500$853,0001.18%
HAMILTON LANE ADVISORS LLC 165,635$151,0000.06%
Redmond Asset Management, LLC 122,477$111,0000.04%
Retirement Planning Co of New England, Inc. 59,069$53,0000.04%
CCG WEALTH MANAGEMENT, LLC 20,000$18,0000.01%
Koshinski Asset Management, Inc. 65,377$59,0000.01%
ZEKE CAPITAL ADVISORS, LLC 93,800$85,0000.01%
K.J. Harrison & Partners Inc 18,300$17,0000.01%
Warberg Asset Management LLC 14,493$13,0000.00%
BLAIR WILLIAM & CO/IL 179,000$163,0000.00%
View complete list of INHIBIKASE THERAPEUTICS INC shareholders